Durable Response of Enzalutamide-resistant Prostate Cancer to Supraphysiological Testosterone Is Associated with a Multifaceted Growth Suppression and Impaired DNA Damage Response Transcriptomic Program in Patient-derived Xenografts

BACKGROUND: Androgen deprivation therapy improves the survival of castration-resistant prostate cancer (CRPC) patients, yet ultimately fails with debilitating side effects. Supraphysiological testosterone (SPT)-based therapy produces clinical responses with improved quality of life in a subset of pa...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Eur Urol
Glavni autori: Lam, Hung-Ming, Nguyen, Holly M., Labrecque, Mark P., Brown, Lisha G., Coleman, Ilsa M., Gulati, Roman, Lakely, Bryce, Sondheim, Daniel, Chatterjee, Payel, Marck, Brett T., Matsumoto, Alvin M., Mostaghel, Elahe A., Schweizer, Michael T., Nelson, Peter S., Corey, Eva
Format: Artigo
Jezik:Inglês
Izdano: 2019
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6920609/
https://ncbi.nlm.nih.gov/pubmed/31227306
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2019.05.042
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items